High prevalence of differentiated thyroid carcinoma in acromegaly
- PMID: 16060909
- DOI: 10.1111/j.1365-2265.2005.02316.x
High prevalence of differentiated thyroid carcinoma in acromegaly
Abstract
Objective: Acromegaly is a chronic disease caused by increased GH secretion and associated with a greater risk of developing both benign and malignant tumours. In the present study we evaluated the prevalence of thyroid disorders and thyroid malignancies in a series of acromegalic subjects.
Design and patients: We studied, retrospectively, a continuous series of 125 acromegalic patients referred to the Endocrinology Centres at the University Hospitals of Catania and Ferrara, Italy, over a 22-year period.
Measurements: Diagnosis and management of acromegaly were based on standardized criteria. In all patients thyroid function and morphology were evaluated by serum free T4, free T3, TSH measurements and ultrasound scanning, respectively. Fine-needle aspiration biopsy (FNAB) was performed in all solid-mixed thyroid nodules of diameter greater than 1 cm. IGF-1 expression was assessed by semiquantitative immunohistochemical analysis in some patients with differentiated thyroid cancer.
Results: Abnormal thyroid function was found in eight cases (6%). A diffuse or nodular goitre was present in 102 cases (82%). Thyroidectomy was performed in 17 patients. Histological examination revealed a differentiated thyroid cancer in seven of the patients. No significant association of thyroid cancer with GH or IGF-1 levels was found. Semiquantitative assessment of IGF-1 expression by immunohistochemistry revealed a more intense staining in thyroid cancer from acromegalic subjects than in papillary thyroid cancer from nonacromegalic subjects.
Conclusions: The frequency of thyroid disorders in our series of acromegalic subjects was similar to that previously observed in these patients. However, the prevalence of thyroid cancer was not only strikingly elevated (5.6%) in comparison to the estimated prevalence in the general population (0.093%), but it was even higher than that reported for acromegalic subjects. Sustained exposure to high serum IGF-1 levels is likely to play a role in the development of thyroid cancer in this disease. An additive role for the autocrine/paracrine action of locally produced IGF-1 is also possible. Our results suggest that thyroid function and morphology should be carefully monitored in all acromegalic patients.
Similar articles
-
The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.Neuro Endocrinol Lett. 2009;30(3):382-6. Neuro Endocrinol Lett. 2009. PMID: 19855364
-
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.J Endocrinol Invest. 2002 Mar;25(3):240-5. doi: 10.1007/BF03343997. J Endocrinol Invest. 2002. PMID: 11936466
-
Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.Horm Metab Res. 2000 May;32(5):190-5. doi: 10.1055/s-2007-978620. Horm Metab Res. 2000. PMID: 10871160
-
Association of primary hyperparathyroidism and non-medullary thyroid cancer.Eur J Surg. 1996 Sep;162(9):685-9. Eur J Surg. 1996. PMID: 8908448 Review.
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
Cited by
-
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.J Endocrinol Invest. 2011 May;34(5):353-60. doi: 10.1007/BF03347459. Epub 2010 Jul 1. J Endocrinol Invest. 2011. PMID: 20595802
-
Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.Med Oncol. 2009;26(1):62-6. doi: 10.1007/s12032-008-9084-9. Epub 2008 Jul 29. Med Oncol. 2009. PMID: 18663612
-
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.J Endocrinol Invest. 2014 Oct;37(10):949-55. doi: 10.1007/s40618-014-0123-4. Epub 2014 Jul 5. J Endocrinol Invest. 2014. PMID: 24996936
-
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.PLoS One. 2014 Jul 14;9(7):e101560. doi: 10.1371/journal.pone.0101560. eCollection 2014. PLoS One. 2014. PMID: 25019383 Free PMC article.
-
Hematologic neoplasias and acromegaly.Pituitary. 2011 Dec;14(4):377-81. doi: 10.1007/s11102-009-0176-0. Pituitary. 2011. PMID: 19337840
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous